Busulfan/dexamethasone interactionLower area under the blood concentration-time curve of busulfan: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2018年 / 1733卷 / 1期
关键词：
D O I：
10.1007/s40278-018-55888-z
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：89 / 89
相关论文
共 50 条
  • [1] Busulfan/deferasirox interactionIncreased busulfan blood concentration: case report
    Reactions Weekly, 2012, 1399 (1) : 10 - 10
  • [2] Limited Sampling Strategies for Estimating Busulfan Area Under the Concentration-Time Curve: Based on Peak and Trough Concentrations in Saliva
    Xu, Baohua
    Zhou, Jianxing
    Zheng, You
    Xu, Ruichao
    Liu, Qingxia
    Li, Dandan
    Liu, Maobai
    Wu, Xuemei
    JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 64 (01): : 58 - 66
  • [3] Two-point blood sampling is sufficient and necessary to estimate the area under the concentration-time curve for intravenous busulfan in infants and young children
    Utano, Tomoyuki
    Kato, Motohiro
    Sakamoto, Kenichi
    Osumi, Tomoo
    Matsumoto, Kana
    Tomizawa, Daisuke
    Matsumoto, Kimikazu
    Yamatani, Akimasa
    PEDIATRIC BLOOD & CANCER, 2021, 68 (08)
  • [4] Maximally Tolerated Busulfan Area Under the Concentration-Time Curve (AUC) In Combination with Fludarabine as Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation
    Perkins, Janelle
    Field, Teresa
    Kim, Jongphil
    Fernandez, Hugo F.
    Perez, Lia
    Ayala, Ernesto
    Kharfan-Dabaja, Mohamed
    Tomblyn, Marcie
    Sullivan, Daniel
    Anasetti, Claudio
    BLOOD, 2010, 116 (21) : 1437 - 1437
  • [5] MAXIMALLY TOLERATED BUSULFAN AREA UNDER THE CONCENTRATION-TIME CURVE (AUC) IN COMBINATION WITH FLUDARABINE AS CONDITIONING PRIOR TO ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
    Perkins, J.
    Fields, T.
    Kim, J.
    Fernandez, H.
    Perez, L.
    Ayala, E.
    Khatfan-Dabaja, M.
    Tomblyn, M.
    Sullivan, D.
    Anasetti, C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S302 - S302
  • [6] IMPACT OF A LOWER BUSULFAN AREA UNDER THE CONCENTRATION-TIME CURVE (AUC) DOSING TARGET ON ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) OUTCOMES
    CruzChacon, A. M.
    Perkins, J. B.
    Pidala, J. A.
    Kim, J.
    Yue, B.
    Field, T.
    Anasetti, C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S340 - S340
  • [7] CONSTANT BLOOD WITHDRAWAL METHOD FOR AREA UNDER PLASMA CONCENTRATION-TIME CURVE
    KOWARSKI, CR
    KOWARSKI, AA
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (06) : 875 - 876
  • [8] TROUGH LEVEL MONITORING OF INTRAVENOUS BUSULFAN TO ESTIMATE THE AREA UNDER THE PLASMA DRUG CONCENTRATION-TIME CURVE IN PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
    Nishikawa, T.
    Watanabe, E.
    Ikawa, K.
    Kodama, Y.
    Tanabe, T.
    Matsumoto, K.
    Okamoto, Y.
    Takeda, Y.
    Kawano, Y.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S227 - S227
  • [9] Trough level monitoring of intravenous busulfan to estimate the area under the plasma drug concentration-time curve in pediatric hematopoietic stem cell transplant recipients
    Watanabe, Erika
    Nishikawa, Takuro
    Ikawa, Kazuro
    Yamaguchi, Hiroki
    Abematsu, Takanari
    Nakagawa, Shunsuke
    Kurauchi, Koichiro
    Kodama, Yuichi
    Tanabe, Takayuki
    Shinkoda, Yuichi
    Matsumoto, Kazuaki
    Okamoto, Yasuhiro
    Takeda, Yasuo
    Kawano, Yoshifumi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 102 (05) : 611 - 616
  • [10] TROUGH LEVEL MONITORING OF INTRAVENOUS BUSULFAN TO ESTIMATE THE AREA UNDER THE PLASMA DRUG CONCENTRATION-TIME CURVE IN PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
    Nishikawa, T.
    Watanabe, E.
    Ikawa, K.
    Kodama, Y.
    Tanabe, T.
    Shinkoda, Y.
    Okamoto, Y.
    Kawano, Y.
    HAEMATOLOGICA, 2015, 100 : 608 - 608
12345